Estrella Immunopharma Inc./$ESLA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.
Ticker
$ESLA
Sector
Primary listing
Employees
-
Headquarters
Website
ESLA Metrics
BasicAdvanced
$43m
-
-$0.35
0.98
-
Price and volume
Market cap
$43m
Beta
0.98
52-week high
$3.15
52-week low
$0.78
Average daily volume
35k
Financial strength
Current ratio
0.242
Quick ratio
0.216
Profitability
Effective tax rate (TTM)
-0.01%
Management effectiveness
Return on assets (TTM)
-271.46%
Return on equity (TTM)
373.21%
Valuation
Price to book
-8.18
Price to tangible book (TTM)
-8.18
Price to free cash flow (TTM)
-4.825
Free cash flow yield (TTM)
-20.72%
Free cash flow per share (TTM)
-0.209
Growth
Earnings per share change (TTM)
20.13%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs